Results 171 to 180 of about 272,512 (195)
Some of the next articles are maybe not open access.
Diagnostic Molecular Pathology, 2001
The MYCN gene is often amplified but rarely rearranged in neuroblastoma. We report, for the first time, a rearrangement within the MYCN coding region in a metastatic neuroblastoma in a 3-year-old boy with MYCN amplification in his primary tumor. The rearrangement occurred 46 nucleotides downstream from the ATG codon in exon 2 of MYCN. The amplification
B, Chen, S C, Jhanwar, M, Ladanyi
openaire +2 more sources
The MYCN gene is often amplified but rarely rearranged in neuroblastoma. We report, for the first time, a rearrangement within the MYCN coding region in a metastatic neuroblastoma in a 3-year-old boy with MYCN amplification in his primary tumor. The rearrangement occurred 46 nucleotides downstream from the ATG codon in exon 2 of MYCN. The amplification
B, Chen, S C, Jhanwar, M, Ladanyi
openaire +2 more sources
MYCN amplification and 17q in neuroblastoma: Evidence for structural association
Genes, Chromosomes and Cancer, 2000MYCN oncogene amplification in neuroblastoma is statistically associated with gain of chromosome segment 17q21-qter. In neuroblastoma cell lines and primary tumors with MYCN amplification in the form of homogeneously staining regions (hsrs), juxtaposition of chromosome 17 material with MYCN sequences has occasionally been reported, raising the ...
S, O'Neill +7 more
openaire +2 more sources
MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma
Cancer Genetics, 2013As prognostic factors, MYC and MYCN amplifications are routinely assessed in medulloblastomas. Fluorescence in situ hybridization (FISH) is currently considered as the technique of reference. Recently, array comparative genomic hybridization (aCGH) has been developed as an alternative technique to evaluate genomic abnormalities in other tumor types ...
Franck, Bourdeaut +13 more
openaire +2 more sources
An Infant With Neuroblastoma and MYCN Amplification Found Through Mass Screening
Journal of Pediatric Hematology/Oncology, 1998This report describes an extremely rare case of an infant with neuroblastoma involving MYCN amplification found through mass screening (MS).An 8-month-old boy was referred to our hospital after screening for neuroblastoma showed positive results. A firm tumor was found above his left kidney and completely resected.The tumor arose from the left adrenal ...
T, Taga +7 more
openaire +2 more sources
The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification
Cancer Letters, 2003Neuroblastoma is a tumour of the peripheral nervous system that accounts for 15% of cancer-related deaths in childhood. Amplification and overexpression of the MYCN proto-oncogene occurs in 25% of neuroblastomas and is highly correlated with treatment failure and mortality.
openaire +2 more sources
MYCN gene amplification in patients with neuroblastic tumors.
Cellular and molecular biology (Noisy-le-Grand, France), 2015Although neuroblastic tumors are the most prevalent solid tumors, little is known about the genetic basis underlying their progression. The prognostic role for the MYCN gene in neuroblastic tumors is irrefutable. The aim of this study is to identify the frequency of MYCN gene amplification and its relationship with clinicopathological and prognostic ...
M A, Estiar +5 more
openaire +1 more source
Circulating MYCN DNA Predicts MYCN-Amplification in Neuroblastoma
Journal of Clinical Oncology, 2005Valérie, Combaret +4 more
openaire +2 more sources
[Study on MYCN gene amplification and CD44 expression in neuroblastoma].
Zhonghua bing li xue za zhi = Chinese journal of pathology, 2005To assess the relationship between MYCN amplification in neuroblastoma (NB), tumor stage and prognosis; and to evaluate the usefulness of CD44 in predicting prognosis of NB.Differential polymerase chain reaction (D-PCR) with serial dilution assay was used to quantify the MYCN gene copy number in 33 paraffin-embedded tissue samples of NB.
Hui-li, Hu, Le-jian, He
openaire +1 more source
Predicting Amplification of MYCN using CpG Methylation Biomarkers in Neuroblastoma
Future Oncology, 2021Hocine Bendou +2 more
exaly

